Physician

Katia E. Taba, MD

According to 2025 Medicare claims, Katia Taba, MD (NPI: 1376768242) practices ophthalmology in the Naples-Marco Island, FL market, with the plurality of this provider's patient population coming from Collier, FL. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS (NPI: 1699773796; TIN: 592086792) and primary practice location at 34109-3884.

Taba's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 548 traditional Medicare patients, billed 25,527 HCPCS/CPT codes, and received $1,803,428 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 341 prescription claims across 135 beneficiaries totaling $129,297 in drug costs, led by Xdemvy (Lotilaner). Open Payments data shows 20 records totaling $805. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $162,559 to $1,803,428. Similarly, Part D prescription costs have moved sharply higher in recent years, from $14,197 to $129,297. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$902K$1.8M2015 Medicare payment: $162,559 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $495,137 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $196,251 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $194,138 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $359,405 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,074,962 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,061,793 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $850,796 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,196,164 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,803,428 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154022,363$162,559
20169067,228$495,137
20174533,102$196,251
20181422,029$194,138
20192073,422$359,405
20204396,432$1,074,962
20214646,380$1,061,793
20224226,522$850,796
202351514,054$1,196,164
202454825,527$1,803,428

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$65K$129K2015 Drug cost: $14,197 (USD; Tot_Drug_Cst)2016 Drug cost: $8,848 (USD; Tot_Drug_Cst)2017 Drug cost: $12,918 (USD; Tot_Drug_Cst)2018 Drug cost: $14,462 (USD; Tot_Drug_Cst)2019 Drug cost: $32,120 (USD; Tot_Drug_Cst)2020 Drug cost: $37,706 (USD; Tot_Drug_Cst)2021 Drug cost: $52,640 (USD; Tot_Drug_Cst)2022 Drug cost: $92,835 (USD; Tot_Drug_Cst)2023 Drug cost: $94,947 (USD; Tot_Drug_Cst)2024 Drug cost: $129,297 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201559150$14,197
20165579$8,848
20175791$12,918
201857117$14,462
201971194$32,120
202090252$37,706
202193319$52,640
2022125444$92,835
2023122367$94,947
2024135341$129,297

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye215933$104
92014Established patient complete exam of visual system324455$99
92012Established patient problem focused exam of visual system275483$72
92134Imaging of retina4621,231$33
92250Photography of the retina399487$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XdemvyLotilaner17802$30,934
XiidraLifitegrast161,080$24,702
RestasisCyclosporine15735$14,944
MieboPerfluorohexyloctane/Pf13594$13,901
CequaCyclosporine12540$10,166

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.20$805Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Katia E. Taba, MD?

Tedicare shows public-source Medicare data for Katia E. Taba, MD (NPI 1376768242), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Katia E. Taba, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Katia E. Taba, MD?

Katia E. Taba, MD is linked to RETINA VITREOUS CONSULTANTS (billing NPI 1699773796) in the available physician profile data.

Does Katia E. Taba, MD have Open Payments data?

Katia E. Taba, MD has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.